FFA
SLS icon

Farther Finance Advisors’s SELLAS Life Sciences SLS Stock Holding History

Farther Finance Advisors’s Portfolio SLS Stock Details SLS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$29.6K Buy
2,407
+47
+2% +$589 ﹤0.01% 3839
2026
Q2 		$34.8K Hold
2,360
– – ﹤0.01% 3541
2026
Q1 		$9.94K Buy
2,360
+2,010
+574% +$8.99K ﹤0.01% 4121
2025
Q4 		$1.32K Buy
+350
New +$680 ﹤0.01% 4840

Other funds holding SLS

EFG
Everhart Financial Group Dublin, Ohio $1.62B AUM 25.73% 1-Year Est. Return
EM
ELCO Management New York $213M AUM 25.23% 1-Year Est. Return
IFG
Independent Financial Group San Diego, California $5.51B AUM 33.52% 1-Year Est. Return
RI
Ridgewood Investments Springfield, New Jersey $271M AUM
FD
Financial Designs Claremont, California $194M AUM 10.52% 1-Year Est. Return
FFBTD
First Financial Bank - Trust Division Hamilton, Ohio $1.39B AUM 15.59% 1-Year Est. Return
GI
GAMMA Investing Foster City, California $2.96B AUM 34.38% 1-Year Est. Return
CA
CoreCap Advisors Southfield, Michigan $3.48B AUM 21.43% 1-Year Est. Return
AAG
Armstrong Advisory Group Needham, Massachusetts $1.66B AUM 13.15% 1-Year Est. Return
VCM
Versant Capital Management Phoenix, Arizona $1.17B AUM 28.44% 1-Year Est. Return

Farther Finance Advisors's SLS Position: Q3 2026 in Review

Farther Finance Advisors increased its SELLAS Life Sciences (SLS) stake by 2% in Q3 2026, buying an estimated $589 and bringing the position to 2,407 shares worth $29.6K. The position accounts for ﹤0.01% of the portfolio, ranked #3839.

Farther Finance Advisors first reported a position in SLS in Q4 2025 and has held it in 4 quarters since. The position peaked at $34.8K in Q2 2026. 12 funds tracked by Wall St. Rank hold SLS as of Q3 2026.

  • Farther Finance Advisors held 2,407 shares of SELLAS Life Sciences worth $29.6K as of Q3 2026.
  • Farther Finance Advisors bought 47 SELLAS Life Sciences shares in Q3 2026, an estimated $589.
  • SELLAS Life Sciences made up ﹤0.01% of Farther Finance Advisors's portfolio in Q3 2026, its #3839 holding.
  • Farther Finance Advisors first reported a position in SELLAS Life Sciences in Q4 2025 and has held it in 4 quarters since.
  • Farther Finance Advisors's SELLAS Life Sciences position peaked at $34.8K in Q2 2026.
  • 12 funds tracked by Wall St. Rank held SELLAS Life Sciences as of Q3 2026.

Based on Farther Finance Advisors's 13F filing for Q3 2026, filed 8 Oct 2026.